Global Peripheral Arterial Disease (PAD) Drugs Market Status and Future Forecast Report 2016-2026
Report ID: 376019 | Oct 2019 | No. of Pages: 50 |
Summary

The global Peripheral Arterial Disease (PAD) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Clinics
Others
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)

Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Peripheral Arterial Disease (PAD) Drugs Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Peripheral Arterial Disease (PAD) Drugs Market by Type
2.1 By Type
2.1.1 Clopidogrel (Plavix)
2.1.2 Prasugrel (Effient)
2.1.3 Ticagrelor (Brilinta)
2.1.4 Vorapaxar (Zontivity)
2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 AstraZeneca Plc. (UK) (Company Profile, Sales Data etc.)
5.2 Bayer HealthCare Pharmaceuticals (Germany) (Company Profile, Sales Data etc.)
5.3 Bristol-Myers Squibb Company (US) (Company Profile, Sales Data etc.)
5.4 Merck & Co., Inc. (US) (Company Profile, Sales Data etc.)
5.5 Proteon Therapeutics, Inc. (US) (Company Profile, Sales Data etc.)
5.6 Sanofi S.A. (France) (Company Profile, Sales Data etc.)
5.7 Symic Bio, Inc. (US) (Company Profile, Sales Data etc.)
5.8 TheraVasc Inc. (US) (Company Profile, Sales Data etc.)
6 Conclusion

List of Table
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2016-2019, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2016-2019, by Type, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, by Type, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Demand 2016-2019, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Demand 2016-2019, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2026, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2026, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Size & Growth 2016-2019, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Size & Growth 2016-2019, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2016-2019, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2016-2019, by Region, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2026, by Region, in Volume
Table AstraZeneca Plc. (UK) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of AstraZeneca Plc. (UK) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Plc. (UK) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of AstraZeneca Plc. (UK) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Pharmaceuticals (Germany) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bayer HealthCare Pharmaceuticals (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bristol-Myers Squibb Company (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Merck & Co., Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Proteon Therapeutics, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Proteon Therapeutics, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. (France) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Sanofi S.A. (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symic Bio, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Symic Bio, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TheraVasc Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of TheraVasc Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)


List of Figure

Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2016-2019, by Type, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2016-2019, by Type, in Volume

1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments

Select License Type
USD $1800
USD $3600
USD $3600
Connect With Us

+1-707-633-0404


Remdesivir Market By Key Manufacturers, By Form (Lyophilized Powder, Concentrated Solution), By Dosage (2.5 MG, 5 MG, 100 MG, 200 MG), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Publication Month: Apr 2021 | No. of Pages: 120
$4250
Buy Now
Blood Compatible Polymers Market By Key Manufacturers, By Type (Polyvinylchloride, Polytetrafluoroethylene, Polyethersulfone, Polyethylene, Polyetheretherketone, Polysulfone, Poly Propalene), By Application (Biomedical and Blood Contacting Devices, Dental, Drug delivery), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Publication Month: Apr 2021 | No. of Pages: 120
$4250
Buy Now
Atrial Fibrillation Market By Key Manufacturers, By Type (EP Ablation Catheters, Cardiac Monitors or Implantable Loop Recorder, EP Diagnostic Catheter, Mapping and Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By Application (EP Ablation, Diagnostic, Surgical), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Publication Month: Apr 2021 | No. of Pages: 120
$4250
Buy Now
Printing Ink Market By Key Manufacturers, By Process (Gravure, Flexographic, Lithographic, Digital, Others), By Application (Corrugated cardboards, Flexible packaging, Tags & Labels, Folding cartons, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Publication Month: Apr 2021 | No. of Pages: 120
$4250
Buy Now
3D Printing Material Market By Key Manufacturers, By Type (Plastic, Metal, Ceramic, Others), By Application (Prototyping, Manufacturing, R&D), By Form (Powder, Filament, Liquid), By Technology (FDM, SLS, SLA, DMLS, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Impact of Covid-19 Analysis on Global Outlook to 2027
Publication Month: Apr 2021 | No. of Pages: 120
$4250
Buy Now